Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population

被引:5
|
作者
Mishra, A. [1 ]
Agrawal, V [2 ]
Krishnani, N. [2 ]
Mishra, S. K. [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pathol, Lucknow 226014, Uttar Pradesh, India
关键词
DTC; oncogene; rearranged during transfection protein; ONCOGENE ACTIVATION; PROTEIN EXPRESSION; GENE REARRANGEMENTS; RET; TUMORS; CHILDREN; LESIONS; SEARCH; CANCER;
D O I
10.4103/0022-3859.57390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The prevalence of Rearranged during Transfection/ Papillary Thyroid Carcinoma (RET/PTC) rearrangement in papillary thyroid carcinoma (PTC) varies in different geographic regions and its prognostic significance remains unclear. Aim: The aim of this study was to recognize the prevalence of RET/PTC expression in PTC from the endemically iodine-deficient region in Northern India and to correlate the expression with the clinicopathologic prognostic factors. Settings and Design: Retrospective. Archival tissue used. Materials and Methods: Immunohistochemistry was performed to look for activated RET protein expression in 50 cases of PTC. No patient had any history of prior irradiation. Statistical Analysis Used: Chi-square method, Student t test, and binary regression method. A P value of <.05 was considered significant for all the tests. Results: The prevalence of RET expression was 44%. Twenty-six (52%) cases showed RET immunoreactivity in histiocytes. Immunoreactivity was the highest in the classic variant of PTC (47.5%), followed by tumors with poorly differentiated areas (25%) and follicular variant (16.7%). RET expression was more prevalent in young patients (45.5 vs. 35.3%), females (43.3 vs. 40.0%), small tumors (33.3 vs. 26.7%), multicentric tumors (36.8 vs. 33.3%), tumors with extrathyroidal invasion (38.9 vs. 32.4%), and regional lymphadenopathy (55.2 vs. 22.2%), while it was less in cases with distant metastases (20 vs. 43.9%). There was no significant correlation of immunoreactivity with any prognostic factor. However, when the cases having immunoreactivity within histiocytes (n = 26) and histiocytes + tumor tissue (n = 28) were considered, then the expression was significantly more in cases with lymphadenopathy (P values =.009, in both instances). However, the exact clinical significance of RET/PTC positive histiocytes remained unexplained. Conclusions: Prevalence of RET/PTC in our study was consistent with the reported prevalence from other geographic areas. There was no significant correlation with the clinicopathologic factors. However, uniform techniques of detection and large international collaborative studies could clear the uncertainties regarding the prognostic importance of RET/PTC.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [21] Prevalence, significance, and biological behavior of ret/PTC1 associated papillary thyroid carcinoma
    Cetta, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05): : 1650 - 1650
  • [22] Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome
    Kjellman, P
    Learoyd, DL
    Messina, M
    Weber, G
    Höög, A
    Wallin, G
    Larsson, C
    Robinson, BG
    Zedenius, J
    BRITISH JOURNAL OF SURGERY, 2001, 88 (04) : 557 - 563
  • [23] Prevalence, significance, and biological behavior of ret/PTC associated papillary thyroid carcinoma - Author's response
    Nikiforov, YE
    Fagin, JA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06): : 2016 - 2017
  • [24] Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia
    Chua, EL
    Wu, WM
    Tran, KT
    McCarthy, SW
    Lauer, CS
    Dubourdieu, D
    Packham, N
    O'Brien, CJ
    Turtle, JR
    Dong, QH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08): : 2733 - 2739
  • [25] High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas
    Lam, KY
    Lo, CY
    Leung, PS
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (06) : 741 - 745
  • [26] Immunohistochemical seperation of thyroid papillary carcinoma follicular variant from follicular adenoma and RET/PTC correlation
    Ozgur, T.
    Atik, E.
    Guray, M.
    Gunesacar, R.
    Canda, T.
    VIRCHOWS ARCHIV, 2012, 461 : S102 - S103
  • [27] HOOK3-RET:: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma
    Ciampi, Raffaele
    Giordano, Thomas J.
    Wikenheiser-Brokamp, Kathryn
    Koenig, Ronald J.
    Nikiforov, Yuri E.
    ENDOCRINE-RELATED CANCER, 2007, 14 (02) : 445 - 452
  • [28] Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas
    Nikiforova, MN
    Caudill, CM
    Biddinger, P
    Nikiforov, YE
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2002, 10 (01) : 15 - 22
  • [29] High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population
    Kang, Dae-Young
    Kim, Kyung-Hee
    Kim, Jin-Man
    Kim, Seok-Hyung
    Kim, Ji-Young
    Baik, Haing-Woon
    Kim, Yong-Sung
    THYROID, 2007, 17 (11) : 1031 - 1038
  • [30] Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters
    Rao, P. Jagan Mohan
    Vardhini, N. V.
    Parvathi, M. V. S.
    Murthy, P. Balakrishna
    Sudhakar, G.
    TUMOR BIOLOGY, 2014, 35 (10) : 9539 - 9548